Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol., 09 September 2025

Sec. Inflammation Pharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1685111

Correction: Research progress in treatment of rheumatoid arthritis with Sinomenine and related formulations based on different administration routes

Wenya WangWenya WangZihui WangZihui WangAixia LingAixia LingChunyan ZhangChunyan ZhangMei LvMei LvLufen HuangLufen HuangYanlian Niu
Yanlian Niu*
  • School of Pharmacy, Jining Medical University, Rizhao, China

A Correction on
Research progress in treatment of rheumatoid arthritis with Sinomenine and related formulations based on different administration routes

by Wang W, Wang Z, Ling A, Zhang C, Lv M, Huang L and Niu Y (2025). Front. Pharmacol. 16:1613679. doi: 10.3389/fphar.2025.1613679

There was a mistake in the caption of Figure 2 as published. Part labels “A,C,E” and “B,D,F” were given, when the labels are “1”, “2”, and “3” according to the figure graphic. The following sentence was also erroneously included (“Reproduced with permission from Wu et al., AAPS PharmSciTech; published by Springer Nature Link, 2024”), and as such has been removed. The corrected caption of Figure 2 appears below.

“Schematic diagram illustrating the mechanism of nanocomposite hydrogel in repairing joint inflammation. (1) The application of drugs to target cells for synergistic effects; (2) The simulation of joint environment to reduce friction; (3) The loading of seed cells onto the nanofiber scaffold to induce chondrocyte differentiation.”

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Sinomenine, mechanism of action, related formulations, drug delivery system, rheumatoid arthritis

Citation: Wang W, Wang Z, Ling A, Zhang C, Lv M, Huang L and Niu Y (2025) Correction: Research progress in treatment of rheumatoid arthritis with Sinomenine and related formulations based on different administration routes. Front. Pharmacol. 16:1685111. doi: 10.3389/fphar.2025.1685111

Received: 13 August 2025; Accepted: 01 September 2025;
Published: 09 September 2025.

Edited and reviewed by:

Olumayokun Olajide, University of Huddersfield, United Kingdom

Copyright © 2025 Wang, Wang, Ling, Zhang, Lv, Huang and Niu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yanlian Niu, bnlsMTAxOEBtYWlsLmpubWMuZWR1LmNu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.